C'est la vie de Mabel

這是菇狗捎來的消息
病友們都好厲害~~~能挖到國外新藥的消息
感覺還是一種跟免疫抑制劑差不多的新藥
希望能這種新藥能讓我趕快擺脫類固醇
按了老半天沒法在他網誌留言..還中了視窗炸彈
不知道是不是他部落格中毒的原因....
為了避免大家中毒在此就不提供他部落格的連結了
感謝這位病友提供的消息
以下是國外新聞,紙擷取其中叫相關的報導
完整翻譯請自行想辦法囉
Merck KgaA Asks EU to Approve Multiple Sclerosis Pill (Update1) >>>
（前兩段好巷沒啥關係...略!!） 
The application “brings us closer to the possibility of providing an oral short-course treatment to patients with multiple sclerosis,” Roberto Gradnik , an executive vice president in Merck's Serono division, said in the statement.中的應用“使我們更接近的可能性提供了一個口頭短期治療多發性硬化患者， ” 羅伯托Gradnik ，執行副總裁在默克雪蘭諾公司的司，在聲明中說。 
＊
Merck presented clinical trial data at the American Academy of Neurology conference in April showing that cladribine halved the risk of relapse, with a side effect in some patients of depleting the white blood cells that protect the body from infection.默克公司的臨床試驗數據，在美國神經學會會議在4月份的一半，表明cladribine復發的風險，並在一些副作用患者臭氧的白血細胞，保護人體免受感染。 Patients who took cladribine were less likely to see their multiple sclerosis progress and more likely not to relapse at all than those on a placebo, the two-year trial showed.患者是誰了cladribine不太可能看到他們的進步和多發性硬化症更有可能不復發，而那些服用安慰劑，兩年試驗表明。 
＊
Five people were diagnosed with cancer, including one case of choriocarcinoma, a cancer of the placenta, in a woman who became pregnant six months after she finished the study. 5人被診斷出患有前列腺癌，其中包括1例絨癌，癌症的胎盤一個女人誰懷孕6個月後，她完成了研究。 
＊
Unlike existing injected medicines for multiple sclerosis, cladribine, approved to fight leukemia more than a decade ago, is taken for a few weeks out of the year in pill form.與現有的注射藥物多發性硬化症， cladribine ，核准打擊白血病10多年前，是採取了幾個星期了，一年中藥丸形式。 The medicine works by suppressing the immune system, blunting its attack on nerve cells.醫藥工程通過抑制免疫系統，鈍化其攻擊的神經細胞。 Merck's pill could compete with an experimental pill from Novartis, FTY720, which disrupts the movement of immune cells into the bloodstream.默克公司的藥丸能與實驗丸由諾華， FTY720 ，這打亂了運動的免疫細胞進入血液。